Insider Holders & Insider Ownership - SURMODICS INC (SRDX)

List of insiders holdings for SURMODICS INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
Ramius LLC
RAMIUS ADVISORS LLC
RAMIUS VALUE & OPPORTUNITY MASTER FUND LTD
Ramius Value & Opportunity Advisors LLC
Cowen Overseas Investment LP
10% Owner		2011-01-06 17:17:192,088,760
0		2,088,760Form 13D
Ramius LLC
C4S & CO LLC
COHEN PETER A
STARK MORGAN B
STRAUSS THOMAS W
SOLOMON JEFFREY M
COWEN GROUP INC.
RCG HOLDINGS LLC
10% Owner		2011-01-06 17:17:192,088,760
0		2,088,760Form 13D
OLSETH DALE R
Director		2011-02-11 14:01:47760,619
0		760,619Form 13G
GUIRE PATRICK E
Senior Vice President		2004-11-12 12:40:49242,329
132,490		374,819Form 5
KOCH DAVID A
Director		2009-01-20 14:38:03325,003
0		325,003Form 13G
Maharaj Gary R
President & CEO		2024-08-23 16:05:18202,582
0		202,582Form 4
VERSEN MARIE J
VP Qual Mgmt & Reg Compliance		2005-02-02 14:45:5190,514
0		90,514Form 4
Arens Timothy J.
Chief Financial Officer		2024-08-20 16:24:3477,359
0		77,359Form 4
SIDES TERI WOODWICK
SVP, Vascular Interventions		2023-12-06 16:47:2965,886
0		65,886Form 4
Stich Joseph J.
SVP of HR, President IVD		2024-08-23 16:06:2663,971
0		63,971Form 4
MILLER LOREN R
Vice President and Controller		2007-08-15 14:33:3962,369
0		62,369Form 4
ANKENY PHILIP D
Interim CEO, Senior VP & CFO		2010-12-02 18:17:0561,983
0		61,983Form 4
BARCLAY BRUCE
President & CEO		2010-02-10 12:54:2956,880
0		56,880Form 4
Wood David S
VP & GM - Drug Del. Bus. Unit		2006-03-22 16:56:0356,808
0		56,808Form 4
OLSON CHARLES W
SVP, Medical Device Coatings		2024-08-20 16:25:1553,971
800		54,771Form 4
OFSTEAD RONALD F
VP Chemistry Development		2004-01-29 16:33:5951,910
0		51,910Form 4
YUNG GREGORY T
VP Sales & Marketing		2005-02-02 14:08:2250,415
0		50,415Form 4
Greaney Thomas A.
COO of Medical Devices		2019-11-27 15:25:3345,681
0		45,681Form 4
CARLSON RICHARD C
VP of Strategic Planning		2004-02-04 13:51:0144,752
0		44,752Form 4
DANTZKER DAVID
Director		2024-02-12 16:16:1242,977
0		42,977Form 4
Weber Gordon S.
Sr. VP of Legal, GC and Sec.		2023-12-06 16:48:0842,924
0		42,924Form 4
KALICH RONALD B SR
Director		2024-02-12 16:12:4642,131
0		42,131Form 4
LaFrence Andrew D. C.
VP of Finance & CFO		2017-11-30 20:24:5941,771
0		41,771Form 4
Starboard Value LP
Starboard Value GP LLC
Starboard Principal Co LP
Starboard Principal Co GP LLC
Smith Jeffrey C
MITCHELL MARK R
Feld Peter A
STARBOARD VALUE & OPPORTUNITY MASTER FUND LTD
See Footnote 1.
10% Owner		2012-09-10 17:24:5041,412
0		41,412Form 13D
KNIGHT SUSAN E
Director		2024-02-12 16:10:1739,303
0		39,303Form 4
Phillips Bryan K
SVP, Gen Counsel & Secretary		2019-12-02 16:10:2035,311
0		35,311Form 4
BEDOYA JOSE H
Director		2024-02-12 16:18:1632,810
0		32,810Form 4
TIPTON ARTHUR J
VP, Pres of Pharmaceuticals		2010-12-02 18:36:1430,991
0		30,991Form 4
Webster Jan M
VP of HR		2010-12-02 18:38:2527,548
0		27,548Form 4
Rusch Eugene C.
VP, Manufacturing		2010-12-02 18:31:1727,548
0		27,548Form 4
Sutton Gregg S
VP of Research and Development		2019-12-02 16:11:3825,263
0		25,263Form 4
FISCHER GERALD B
Director		2014-12-05 15:29:3921,133
0		21,133Form 4
KEOUGH STEVEN J
Sr VP/Gen Mgr Orth/Chf IP Cnsl		2008-03-25 19:07:4119,943
0		19,943Form 4
BENSON JOHN W
Director		2015-12-22 17:29:4718,565
0		18,565Form 4
Lopez Paul A
VP, President - Ophthamology		2010-02-10 13:14:2518,283
0		18,283Form 4
Heine Lisa Wipperman
Director		2024-02-12 16:08:1217,306
0		17,306Form 4
MESLOW JOHN A
Director		2010-12-02 18:07:0616,528
0		16,528Form 4
KELLER KENNETH H
Director		2010-12-02 18:02:5216,528
0		16,528Form 4
Shoup Michael J
VP of Qual, Reg & Clinical		2010-02-10 13:21:2816,251
0		16,251Form 4
McCormick Shawn
Director		2020-02-18 16:35:5613,428
0		13,428Form 4
NICHOLS JANE M
Vice President Marketing		2004-01-29 16:33:1912,500
0		12,500Form 4
Anderson Aron B
VP & Chief Scientific Officer		2010-02-10 12:47:1612,189
0		12,189Form 4
DURAN LISE W
VP of Research		2010-02-10 12:59:2812,189
0		12,189Form 4
BUHRMASTER ROBERT C
Director		2014-02-06 17:09:1711,672
0		11,672Form 4
Manders John D.
Corporate Controller		2023-12-06 16:46:5411,479
0		11,479Form 4
Robey Brian L
Sr VP, Product Development		2010-05-18 16:27:071,233
9,432		10,665Form 4
NELSON TIMOTHY S
Director		2014-12-05 15:32:0310,606
0		10,606Form 4
MELROSE KENDRICK B
Director		2008-11-19 19:19:4910,000
0		10,000Form 4/A
WARD SCOTT R
Director		2014-12-05 15:32:449,783
0		9,783Form 4
ASTRY DOUGLAS P
Gen Mgr, In Vitro Technologies		2010-02-10 12:51:598,126
0		8,126Form 4
Lehman Mark A.
Corporate Controller		2014-11-20 17:20:506,957
0		6,957Form 4
Sultana Nusrath
VP, Clinical Affairs		2022-02-14 16:41:066,530
0		6,530Form 4
Ginsberg Peter L
VPof Bus Devlpmt & Strat Plan		2008-05-21 16:35:175,527
0		5,527Form 4
BRAINERD MARY K
Former Director
Director		2014-05-09 17:40:394,729
0		4,729Form 4
Seibert Amy E.
Principal Accounting Officer		2016-05-02 15:55:081,645
0		1,645Form 4
Middleton John C.
VP, Drug Del, Product Dev		2010-08-03 14:19:561,643
0		1,643Form 4
Meckler Jeffrey A
See Explanation of Responses		2010-12-03 18:29:070
0		0Form 3